Related references
Note: Only part of the references are listed.Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1
Yuhui Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
LncRNA H19 regulates PI3K-Akt signal pathway by functioning as a ceRNA and predicts poor prognosis in colorectal cancer: integrative analysis of dysregulated ncRNA-associated ceRNA network
Min-Er Zhong et al.
CANCER CELL INTERNATIONAL (2019)
Histone deacetylase inhibitor SAHA-induced epithelial-mesenchymal transition by upregulating Slug in lung cancer cells
Jun Wang et al.
ANTI-CANCER DRUGS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis
Yan Chen et al.
CANCER MEDICINE (2017)
MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer
Q. D. Mao et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition
Yi Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients
Zhen Lv et al.
MOLECULAR CARCINOGENESIS (2016)
Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer
Hanlin Zeng et al.
CANCER CELL (2016)
HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer
Junyi He et al.
ONCOTARGET (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition
Ching-Wen Lin et al.
STEM CELLS INTERNATIONAL (2016)
The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory
Eli Raveh et al.
MOLECULAR CANCER (2015)
HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells
Meiying Ji et al.
ONCOLOGY REPORTS (2015)
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
Wei-Cheng Liang et al.
ONCOTARGET (2015)
EMT and tumor metastasis
Sarah Heerboth et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma
Sridurga Mithraprabhu et al.
EPIGENETICS (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675
Yan Shi et al.
PLOS ONE (2014)
Targeting EMT in cancer: opportunities for pharmacological intervention
Felicity M. Davis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells
Cong-Chong Yang et al.
BMC CANCER (2013)
Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
Ming Luo et al.
CANCER LETTERS (2013)
HDAC Up-Regulation in Early Colon Field Carcinogenesis Is Involved in Cell Tumorigenicity through Regulation of Chromatin Structure
Yolanda Stypula-Cyrus et al.
PLOS ONE (2013)
A one-step cloning method for the construction of somatic cell gene targeting vectors: application to production of human knockout cell lines
Yi Liu et al.
BMC BIOTECHNOLOGY (2012)
HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy
Kuen-Tyng Lin et al.
CLINICAL CANCER RESEARCH (2012)
Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
Ali Aghdassi et al.
GUT (2012)
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
V. Byles et al.
ONCOGENE (2012)
Frequent Alterations and Epigenetic Silencing of Differentiation Pathway Genes in Structurally Rearranged Liposarcomas
Barry S. Taylor et al.
CANCER DISCOVERY (2011)
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Ina Oehme et al.
CLINICAL CANCER RESEARCH (2009)
Transforming pathways unleashed by a HDAC2 mutation in human cancer
S. Ropero et al.
ONCOGENE (2008)
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays
Mitchell Stark et al.
CANCER RESEARCH (2007)
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
S Ropero et al.
NATURE GENETICS (2006)
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients
H Osada et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
P Zhu et al.
CANCER CELL (2004)
Share Paper
